human acute myeloid leukemia (AML) cells
human acute myeloid leukemia (AML) cells
human acute myeloid leukemia (AML) cells
human acute myeloid leukemia (AML) cells
human acute myeloid leukemia (AML) cells
human acute myeloid leukemia (AML) cells
human acute myeloid leukemia (AML) cells
human acute myeloid leukemia (AML) cells
human acute myeloid leukemia (AML) cells
human acute myeloid leukemia (AML) cells
human acute myeloid leukemia (AML) cells
human acute myeloid leukemia (AML) cells
human acute myeloid leukemia (AML) cells
human acute myeloid leukemia (AML) cells
human acute myeloid leukemia (AML) cells
human acute myeloid leukemia (AML) cells
human acute myeloid leukemia (AML) cells
human acute myeloid leukemia (AML) cells
human acute myeloid leukemia (AML) cells
human acute myeloid leukemia (AML) cells
human acute myeloid leukemia (AML) cells
human acute myeloid leukemia (AML) cells
human acute myeloid leukemia (AML) cells
human acute myeloid leukemia (AML) cells
human acute myeloid leukemia (AML) cells
human acute myeloid leukemia (AML) cells

increasing dose of venetoclax for 8 weeks